|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Llovet JM, Kelley RK, Villanueva A, Singal
AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and
Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers.
7(6)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ker CG: Hepatobiliary surgery in Taiwan:
The past, present, and future. Part I; biliary surgery. Formosan J
Surg. 57:1–10. 2024.
|
|
4
|
Alim Al-Bari A, Ito Y, Thomes PG, Menon
MB, García-Macia M, Fadel R, Stadlin A, Peake N, Faris ME, Eid N
and Klionsky DJ: Emerging mechanistic insights of selective
autophagy in hepatic diseases. Front Pharmacol.
14(1149809)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nguyen TH, Nguyen TM, Ngoc DTM, You T,
Park MK and Lee CH: Unraveling the janus-faced role of autophagy in
hepatocellular carcinoma: Implications for therapeutic
interventions. Int J Mol Sci. 24(16255)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S,
Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abud
YP, Acevedo-Arozena A, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy (4th edition).
Autophagy. 17:1–382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Vainshtein A and Grumati P: Selective
autophagy by close encounters of the ubiquitin kind. Cells.
9(2349)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Narendra DP, Jin SM, Tanaka A, Suen DF,
Gautier CA, Shen J, Cookson MR and Youle RJ: PINK1 is selectively
stabilized on impaired mitochondria to activate Parkin. PLoS Biol.
8(e1000298)2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Youle RJ and Narendra DP: Mechanisms of
mitophagy. Nat Rev Mol Cell Biol. 12:9–14. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang F, Denison S, Lai JP, Philips LA,
Montoya D, Kock N, Schüle B, Klein C, Shridhar V, Roberts LR and
Smith DI: Parkin gene alterations in hepatocellular carcinoma.
Genes Chromosomes Cancer. 40:85–96. 2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Feng J, Zhou J, Wu Y, Shen HM, Peng T and
Lu GD: Targeting mitophagy as a novel therapeutic approach in liver
cancer. Autophagy. 19:2164–2165. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Szargel R, Shani V, Elghani FA, Mekies LN,
Liani E, Rott R and Engelender S: The PINK1, synphilin-1 and SIAH-1
complex constitutes a novel mitophagy pathway. Hum Mol Genet.
25:3476–3490. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhou J, Feng J, Wu Y, Dai HQ, Zhu GZ, Chen
PH, Wang LM, Lu G, Liao XW, Lu PZ, et al: Simultaneous treatment
with sorafenib and glucose restriction inhibits hepatocellular
carcinoma in vitro and in vivo by impairing SIAH1-mediated
mitophagy. Exp Mol Med. 54:2007–2021. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Luo P, An Y, He J, Xing X, Zhang Q, Liu X,
Chen Y, Yuan H, Chen J, Wong YK, et al: Icaritin with
autophagy/mitophagy inhibitors synergistically enhances anticancer
efficacy and apoptotic effects through PINK1/Parkin-mediated
mitophagy in hepatocellular carcinoma. Cancer Lett.
587(216621)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang S, Wang Y, Cao Y, Wu J, Zhang Z, Ren
H, Xu X, Kaznacheyeva E, Li Q and Wang G: Inhibition of the
PINK1-parkin pathway enhances the lethality of sorafenib and
regorafenib in hepatocellular carcinoma. Front Pharmacol.
13(851832)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ma M, Lin XH, Liu HH, Zhang R and Chen RX:
Suppression of DRP1-mediated mitophagy increases the apoptosis of
hepatocellular carcinoma cells in the setting of chemotherapy.
Oncol Rep. 43:1010–1018. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Aman Y, Cao S and Fang EF: Iron out,
mitophagy in! A way to slow down hepatocellular carcinoma. EMBO
Rep. 21(e51652)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kim SJ, Khan M, Quan J, Till A, Subramani
S and Siddiqui A: Hepatitis B virus disrupts mitochondrial
dynamics: Induces fission and mitophagy to attenuate apoptosis.
PLoS Pathog. 9(e1003722)2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li Y and Ou JJ: Regulation of
mitochondrial metabolism by hepatitis B virus. Viruses.
15(2359)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen YY, Wang WH, Che L, Lan Y, Zhang LY,
Zhan DL, Huang ZY, Lin ZN and Lin YC: BNIP3L-dependent mitophagy
promotes HBx-induced cancer stemness of hepatocellular carcinoma
cells via glycolysis metabolism reprogramming. Cancers (Basel).
12(655)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jia P, Tian T, Li Z, Wang Y, Lin Y, Zeng
W, Ye Y, He M, Ni X, Pan J, et al: CCDC50 promotes tumor growth
through regulation of lysosome homeostasis. EMBO Rep.
24(e56948)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Eapen VV, Swarup S, Hoyer MJ, Paulo JA and
Harper JW: Quantitative proteomics reveals the selectivity of
ubiquitin-binding autophagy receptors in the turnover of damaged
lysosomes by lysophagy. Elife. 10(e72328)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hoyer MJ, Swarup S and Harper JW:
Mechanisms controlling selective elimination of damaged lysosomes.
Curr Opin Physiol. 29(100590)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang Y, Wang Z, Sun J and Qian Y:
Identification of HCC subtypes with different prognosis and
metabolic patterns based on mitophagy. Front Cell Dev Biol.
9(799507)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF,
Gu CY, Yang H, Shi GM, Ke AW, Wang XY, et al: Autophagy activation
in hepatocellular carcinoma contributes to the tolerance of
Oxaliplatin via reactive oxygen species modulation. Clin Cancer
Res. 17:6229–6238. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Brun S, Bestion E, Raymond E, Bassissi F,
Jilkova ZM, Mezouar S, Rachid M, Novello M, Tracz J, Hamaï A, et
al: GNS561, a clinical-stage PPT1 inhibitor, is efficient against
hepatocellular carcinoma via modulation of lysosomal functions.
Autophagy. 18:678–694. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bi T, Lu Q, Pan X, Dong F, Hu Y, Xu Z, Xiu
P, Liu Z and Li J: circFAM134B is a key factor regulating
reticulophagy-mediated ferroptosis in hepatocellular carcinoma.
Cell Cycle. 22:1900–1920. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu Z, Ma C, Wang Q, Yang H, Lu Z, Bi T,
Xu Z, Li T, Zhang L, Zhang Y, et al: Targeting FAM134B-mediated
reticulophagy activates sorafenib-induced ferroptosis in
hepatocellular carcinoma. Biochem Biophys Res Commun. 589:247–253.
2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wu H, Liu Q, Shan X, Gao W and Chen Q: ATM
orchestrates ferritinophagy and ferroptosis by phosphorylating
NCOA4. Autophagy. 19:2062–2077. 2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wei X, Manandhar L, Kim H, Chhetri A,
Hwang J, Jang G, Park C and Park R: Pexophagy and oxidative stress:
Focus on peroxisomal proteins and reactive oxygen species (ROS)
signaling pathways. Antioxidants (Basel). 14(126)2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dutta RK, Maharjan Y, Lee JN, Park C, Ho
YS and Park R: Catalase deficiency induces reactive oxygen species
mediated pexophagy and cell death in the liver during prolonged
fasting. Biofactors. 47:112–125. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ohshima K, Hara E, Takimoto M, Bai Y,
Hirata M, Zeng W, Uomoto S, Todoroki M, Kobayashi M, Kozono T, et
al: Peroxisome proliferator activator α agonist clofibrate induces
pexophagy in coconut oil-based high-fat diet-fed rats. Biology
(Basel). 13(1027)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Deosaran E, Larsen KB, Hua R, Sargent G,
Wang Y, Kim S, Lamark T, Jauregui M, Law K, Lippincott-Schwartz J,
et al: NBR1 acts as an autophagy receptor for peroxisomes. J Cell
Sci. 126:939–952. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li Y, Jiang X, Zhang Y, Gao Z, Liu Y, Hu
J, Hu X, Li L, Shi J and Gao N: Nuclear accumulation of UBC9
contributes to SUMOylation of lamin A/C and nucleophagy in response
to DNA damage. J Exp Clin Cancer Res. 38(67)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Papandreou ME and Tavernarakis N:
Nucleophagy: From homeostasis to disease. Cell Death Differ.
26:630–639. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Cebollero E, Reggiori F and Kraft C:
Reticulophagy and ribophagy: Regulated degradation of protein
production factories. Int J Cell Biol. 2012(182834)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu Y, Zou W, Yang P, Wang L, Ma Y, Zhang
H and Wang X: Autophagy-dependent ribosomal RNA degradation is
essential for maintaining nucleotide homeostasis during C. elegans
development. eLife. 7(e36588)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wyant GA, Abu-Remaileh M, Frenkel EM,
Laqtom NN, Dharamdasani V, Lewis CA, Chan SH, Heinze I, Ori A and
Sabatini DM: NUFIP1 is a ribosome receptor for starvation-induced
ribophagy. Science. 360:751–758. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xu F, Tautenhahn HM, Dirsch O and Dahmen
U: Blocking autophagy with chloroquine aggravates lipid
accumulation and reduces intracellular energy synthesis in
hepatocellular carcinoma cells, both contributing to its
anti-proliferative effect. J Cancer Res Clin Oncol. 148:3243–3256.
2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Xu C and Fan J: Links between autophagy
and lipid droplet dynamics. J Exp Bot. 73:2848–2858.
2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Berardi DE, Bock-Hughes A, Terry AR, Drake
LE, Bozek G and Macleod KF: Lipid droplet turnover at the lysosome
inhibits growth of hepatocellular carcinoma in a BNIP3-dependent
manner. Sci Adv. 8(eabo2510)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Koutsifeli P, Varma U, Daniels LJ,
Annandale M, Li X, Neale JPH, Hayes S, Weeks KL, James S, Delbridge
LMD and Mellor KM: Glycogen-autophagy: Molecular machinery and
cellular mechanisms of glycophagy. J Biol Chem.
298(102093)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gade TPF, Tucker E, Nakazawa MS, Hunt SJ,
Wong W, Krock B, Weber CN, Nadolski GJ, Clark TWI, Soulen MC, et
al: Ischemia induces quiescence and autophagy dependence in
hepatocellular carcinoma. Radiology. 283:702–710. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xiu Z, Zhu Y, Han J, Li Y, Yang X, Yang G,
Song G, Li S, Li Y, Cheng C, et al: Caryophyllene oxide induces
ferritinophagy by regulating the NCOA4/FTH1/LC3 pathway in
hepatocellular carcinoma. Front Pharmacol.
13(930958)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang G, Li J, Zhu L, Zhou Z, Ma Z, Zhang
H, Yang Y, Niu Q and Wang X: Identification of hepatocellular
carcinoma-related subtypes and development of a prognostic model: A
study based on ferritinophagy-related genes. Discov Oncol.
14(147)2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Subburayan K, Thayyullathil F,
Pallichankandy S, Cheratta AR, Alakkal A, Sultana M, Drou N, Arshad
M, Palanikumar L, Magzoub M, et al: Tumor suppressor Par-4
activates autophagy-dependent ferroptosis. Commun Biol.
7(732)2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yang H, Sun W, Bi T, Wang Q, Wang W, Xu Y,
Liu Z and Li J: The PTBP1-NCOA4 axis promotes ferroptosis in liver
cancer cells. Oncol Rep. 49(45)2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Santana-Codina N, del Rey MQ, Kapner KS,
Zhang H, Gikandi A, Malcolm C, Poupault C, Kuljanin M, John KM,
Biancur DE, et al: NCOA4-Mediated ferritinophagy is a pancreatic
cancer dependency via maintenance of iron bioavailability for
iron-sulfur cluster proteins. Cancer Discov. 12:2180–2197.
2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yang Z, Yoshii SR, Sakai Y, Zhang J, Chino
H, Knorr RL and Mizushima N: Autophagy adaptors mediate
Parkin-dependent mitophagy by forming sheet-like liquid
condensates. EMBO J. 43:5613–5634. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Agudo-Canalejo J, Schultz SW, Chino H,
Migliano SM, Saito C, Koyama-Honda I, Stenmark H, Brech A, May AI,
Mizushima N and Knorr RL: Wetting regulates autophagy of
phase-separated compartments and the cytosol. Nature. 591:142–146.
2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Mangiarotti A, Sabri E, Schmidt KV,
Hoffmann C, Milovanovic D, Lipowsky R and Dimova R: Lipid packing
and cholesterol content regulate membrane wetting and remodeling by
biomolecular condensates. Nat Commun. 16(2756)2025.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Mangiarotti A, Chen N, Zhao Z, Lipowsky R
and Dimova R: Wetting and complex remodeling of membranes by
biomolecular condensates. Nat Commun. 14(2809)2023.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ohshima T, Yamamoto H, Sakamaki Y, Saito C
and Mizushima N: NCOA4 drives ferritin phase separation to
facilitate macroferritinophagy and microferritinophagy. J Cell
Biol. 221(e202203102)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Cerda-Troncoso C, Varas-Godoy M and Burgos
PV: Pro-tumoral functions of autophagy receptors in the modulation
of cancer progression. Front Oncol. 10(619727)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Brun S, Pascussi JM, Gifu EP, Bestion E,
Macek-Jilkova Z, Wang G, Bassissi F, Mezouar S, Courcambeck J,
Merle P, et al: GNS561, a new autophagy inhibitor active against
cancer stem cells in hepatocellular carcinoma and hepatic
metastasis from colorectal cancer. J Cancer. 12:5432–5438.
2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Shalhoub H, Gonzalez P, Dos Santos A,
Guillermet-Guibert J, Moniaux N, Dupont N and Faivre J:
Simultaneous activation and blockade of autophagy to fight
hepatocellular carcinoma. Autophagy Rep. 3(2326241)2024.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Qian R, Cao G, Su W, Zhang J, Jiang Y,
Song H, Jia F and Wang H: Enhanced sensitivity of tumor cells to
autophagy inhibitors using fasting-mimicking diet and targeted
lysosomal delivery nanoplatform. Nano Lett. 22:9154–9162.
2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Liu C, Wu Z, Wang L, Yang Q and Huang J
and Huang J: A mitophagy-related gene signature for subtype
identification and prognosis prediction of hepatocellular
carcinoma. Int J Mol Sci. 23(12123)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Umemura A, He F, Taniguchi K, Nakagawa H,
Yamachika S, Font-Burgada J, Zhong Z, Subramaniam S, Raghunandan S,
Duran A, et al: p62, Upregulated during preneoplasia, induces
hepatocellular carcinogenesis by maintaining survival of stressed
HCC-initiating cells. Cancer Cell. 29:935–948. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Saito T, Ichimura Y, Taguchi K, Suzuki T,
Mizushima T, Takagi K, Hirose Y, Nagahashi M, Iso T, Fukutomi T, et
al: p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular
carcinoma through Nrf2-dependent metabolic reprogramming. Nat
Commun. 7(12030)2016.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Meng YC, Lou XL, Yang LY, Li D and Hou YQ:
Role of the autophagy-related marker LC3 expression in
hepatocellular carcinoma: A meta-analysis. J Cancer Res Clin Oncol.
146:1103–1113. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Qiu DM, Wang GL, Chen L, Xu YY, He S, Cao
XL, Qin J, Zhou JM, Zhang YX and Qun E: The expression of beclin-1,
an autophagic gene, in hepatocellular carcinoma associated with
clinical pathological and prognostic significance. BMC Cancer.
14(327)2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Lin CW, Chen YS, Lin CC, Lee PH, Lo GH,
Hsu CC, Hsieh PM, Koh KW, Chou TC, Dai CY, et al: Autophagy-related
gene LC3 expression in tumor and liver microenvironments
significantly predicts recurrence of hepatocellular carcinoma after
surgical resection. Clin Transl Gastroenterol.
9(166)2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cao J, Wu L, Lei X, Shi K and Shi L: A
signature of 13 autophagy-related gene pairs predicts prognosis in
hepatocellular carcinoma. Bioengineered. 12:697–707.
2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wang S, Cheng H, Li M, Gao D, Wu H, Zhang
S, Huang Y and Guo K: BNIP3-mediated mitophagy boosts the
competitive growth of Lenvatinib-resistant cells via energy
metabolism reprogramming in HCC. Cell Death Dis.
15(484)2024.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Bassissi F, Jílková Z, Brun S, Courcambeck
J, Tracz J, Kurma K, Roth GS, Khaldi C, Chaimbault C, Quentin B, et
al: Abstract 5124: GNS561 a new quinoline derivative inhibits the
growth of hepatocellular carcinoma in a cirrhotic rat and human PDX
orthotopic mouse models. Cancer Res. 77 (Suppl 13)(5124)2017.
|
|
68
|
Miao Y, Yin Q, Ping L, Sheng H, Chang J,
Li W and Lv S: Pseudolaric acid B triggers ferritinophagy and
ferroptosis via upregulating NCOA4 in lung adenocarcinoma cells. J
Cancer Res Ther. 19:1646–1653. 2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhu J, Wang M and Hu D: Development of an
autophagy-related gene prognostic signature in lung adenocarcinoma
and lung squamous cell carcinoma. PeerJ. 8(e8288)2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Rahdan F, Abedi F, Dianat-Moghadam H, Sani
MZ, Taghizadeh M and Alizadeh E: Autophagy-based therapy for
hepatocellular carcinoma: from standard treatments to combination
therapy, oncolytic virotherapy, and targeted nanomedicines. Clin
Exp Med. 25(13)2024.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Zai W, Chen W, Han Y, Wu Z, Fan J, Zhang
X, Luan J, Tang S, Jin X, Fu X, et al: Targeting PARP and autophagy
evoked synergistic lethality in hepatocellular carcinoma.
Carcinogenesis. 41:345–357. 2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Qian M, Wan Z, Liang X, Jing L, Zhang H,
Qin H, Duan W, Chen R, Zhang T, He Q, et al: Targeting autophagy in
HCC treatment: Exploiting the CD147 internalization pathway. Cell
Commun Signal. 22(583)2024.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Macleod K: Abstract 4984: BNip3 suppresses
hepatocellular carcinoma (HCC) growth by limiting lipogenesis.
Cancer Res. 77 (Suppl 13)(4984)2017.
|
|
74
|
Zai W, Chen W, Liu H and Yuxuan H:
MO1-5-3-Compromised autophagy sensitizes hepatocellular carcinoma
to PARP inhibition. Ann Oncol. 30:vi91–vi2. 2019.
|
|
75
|
Sadagopan N and He AR: Recent progress in
systemic therapy for advanced hepatocellular carcinoma. Int J Mol
Sci. 25(1259)2024.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Byrnes K, Blessinger S, Bailey NT, Scaife
R, Liu G and Khambu B: Therapeutic regulation of autophagy in
hepatic metabolism. Acta Pharm Sin B. 12:33–49. 2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Allaire M, Rautou PE, Codogno P and
Lotersztajn S: Autophagy in liver diseases: Time for translation? J
Hepatol. 70:985–998. 2019.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Martini G, Ciardiello D, Paragliola F,
Nacca V, Santaniello W, Urraro F, Stanzione M, Niosi M, Dallio M,
Federico A, et al: How immunotherapy has changed the continuum of
care in hepatocellular carcinoma. Cancers (Basel).
13(4719)2021.PubMed/NCBI View Article : Google Scholar
|
